Indication
Antipsychotic-induced Weight Gain
2 clinical trials
2 products
Clinical trial
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Miricorilant (CORT118335) in Obese Adult Patients With Schizophrenia or Bipolar Disorder and Recent Weight Gain While Taking Antipsychotic Medications (GRATITUDE)Status: Completed, Estimated PCD: 2022-12-31
Product
MiricorilantProduct
MiricorlilantClinical trial
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Miricorilant in Obese Adult Patients With Schizophrenia Taking Antipsychotic Medications (GRATITUDE II)Status: Completed, Estimated PCD: 2023-01-31